NCT00229385View on ClinicalTrials.gov

Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive Disorder (OCD)

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2010

Conditions
SchizophreniaObsessive Compulsive Disorder
Interventions
DRUG

Ziprasidone

40-80 mg BID

Trial Locations (1)

52621

Chaim Sheba Medical Center, Ramat Gan

All Listed Sponsors
lead

Sheba Medical Center

OTHER_GOV

NCT00229385 - Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive Disorder (OCD) | Biotech Hunter | Biotech Hunter